|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.881
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.825
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.767
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.728
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.695
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.677
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.675
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.653
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.649
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.637
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.630
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.596
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.581
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.580
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.568
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.547
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.543
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.510
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.510
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.507
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.506
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.499
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.495
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.495
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.487
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.484
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.480
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.476
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.475
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.470
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.459
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.454
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.448
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.440
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.426
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.415
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.413
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.411
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.407
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.404
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.401
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.392
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.390
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.390
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.382
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.380
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.369
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.367
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.364
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.362
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.353
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.353
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.352
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.347
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.339
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.333
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.327
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.319
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
18 |
0.319
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.309
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.308
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.303
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.302
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.296
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.295
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.294
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.293
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.290
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.290
|
|
|
|
cell surface receptor signaling pathway involved in heart development
|
GO:0061311 |
15 |
0.288
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.287
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.283
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.280
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.277
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.274
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.271
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.269
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.266
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.261
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.261
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.259
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.258
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.251
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.251
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.249
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.249
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.249
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.248
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.243
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.240
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.240
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.238
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.235
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.234
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.234
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.233
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.232
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.230
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.230
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.228
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.227
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.227
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.225
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.225
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.221
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.219
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.219
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.218
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.216
|
Zebrafish |
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.215
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.211
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.209
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.208
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.207
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.206
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.204
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.204
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.203
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.202
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.200
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.198
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.198
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.196
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.195
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.195
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.192
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.192
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.192
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.192
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.189
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.189
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.189
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.188
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.187
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.186
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.185
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.184
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.184
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.181
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.181
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.180
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.178
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.178
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.176
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.175
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.175
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.174
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.173
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.167
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.166
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.165
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.165
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.164
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.162
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.162
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.160
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.160
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.159
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.159
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.158
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.157
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.157
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.157
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.157
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.156
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.155
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.155
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.155
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.154
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.154
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.152
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.152
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.151
|
|
|
|
cellular response to heparin
|
GO:0071504 |
1 |
0.149
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.149
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.148
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.147
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.146
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.145
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.145
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.144
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.144
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.142
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.142
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.141
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.141
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.140
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.139
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.139
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.137
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.137
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.136
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.135
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.135
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.134
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.130
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.130
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.129
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.128
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.128
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.127
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.127
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.127
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
13 |
0.126
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.126
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.125
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.125
|
|
|
|
coronary artery morphogenesis
|
GO:0060982 |
6 |
0.124
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.124
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.123
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.123
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.123
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.122
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.121
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.120
|
|
|
|
germ line sex determination
|
GO:0018992 |
3 |
0.120
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.120
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.120
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.119
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.119
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.118
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.118
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.118
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.117
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.116
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.116
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.116
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.115
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.115
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.115
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.114
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.114
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.113
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.113
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.113
|
|
|
|
ascending aorta morphogenesis
|
GO:0035910 |
3 |
0.113
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.112
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.112
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
21 |
0.111
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
28 |
0.111
|
|
|
|
myoblast proliferation
|
GO:0051450 |
11 |
0.110
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.110
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.109
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.109
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.108
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.108
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.107
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.106
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.106
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.106
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.105
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.105
|
|
|
|
positive regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014718 |
2 |
0.104
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.104
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.104
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.104
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.104
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.104
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.103
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.103
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.103
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.102
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.102
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.102
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.102
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.101
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.101
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.101
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.101
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.101
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.101
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.101
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.100
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.099
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.099
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.099
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.099
|
|
|
|
glial cell fate commitment
|
GO:0021781 |
14 |
0.098
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.098
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.096
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.096
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.096
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.095
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.095
|
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.095
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.094
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.094
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.094
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.094
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.094
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.093
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.093
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.093
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.092
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.092
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.092
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.092
|
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.091
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.091
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.090
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.090
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.089
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.089
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.089
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.089
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.089
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.089
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.089
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.089
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.088
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.088
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.087
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.086
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.086
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.086
|
|
|
|
gall bladder development
|
GO:0061010 |
2 |
0.085
|
|
|
|
detection of mechanical stimulus involved in equilibrioception
|
GO:0050973 |
2 |
0.085
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.085
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.084
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.084
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.084
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.083
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.083
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.083
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.082
|
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.082
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.082
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.082
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.082
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.082
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.081
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.081
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.081
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.079
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.079
|
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
22 |
0.078
|
|
|
|
male germ line sex determination
|
GO:0019100 |
2 |
0.078
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.078
|
|
|
|
renal vesicle development
|
GO:0072087 |
17 |
0.078
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.078
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.078
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.077
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.077
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.077
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.077
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.077
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.077
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.077
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.076
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
13 |
0.076
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.076
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.076
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.076
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.076
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.075
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.075
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.075
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.074
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.074
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.074
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.073
|
|
|
|
endodermal digestive tract morphogenesis
|
GO:0061031 |
4 |
0.073
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.073
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.073
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.072
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.072
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.072
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.072
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.072
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.071
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.071
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.071
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.070
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.070
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.070
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.070
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.070
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.070
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.070
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.070
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.070
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.070
|
|
|
|
sympathetic nervous system development
|
GO:0048485 |
22 |
0.069
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.069
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.069
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.069
|
|
|
|
renal vesicle morphogenesis
|
GO:0072077 |
15 |
0.069
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.068
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.068
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.068
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.068
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.068
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.067
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.067
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.067
|
|
|
|
coronary vasculature development
|
GO:0060976 |
12 |
0.067
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.067
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.066
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.066
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.066
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.065
|
|
|
|
regulation of stem cell division
|
GO:2000035 |
4 |
0.065
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.064
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.064
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.064
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.064
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.064
|
|
|
|
negative regulation of t helper 2 cell differentiation
|
GO:0045629 |
4 |
0.064
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.064
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.064
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.063
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.063
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.063
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.063
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.063
|
|
|
|
neuron fate determination
|
GO:0048664 |
9 |
0.063
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.063
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.063
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.063
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.062
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.062
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.062
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.061
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.061
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.061
|
|
|
|
response to heparin
|
GO:0071503 |
1 |
0.061
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.061
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.061
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.061
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.061
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.061
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.060
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.060
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
15 |
0.060
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.060
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.060
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.059
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.059
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.059
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.059
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.059
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.059
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.059
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.059
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.058
|
|
|
|
renal system vasculature development
|
GO:0061437 |
15 |
0.058
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.058
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.058
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.058
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.058
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.058
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.058
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.057
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.057
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.057
|
|
|
|
positive regulation of exit from mitosis
|
GO:0031536 |
1 |
0.057
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.057
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.057
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.057
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.057
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.056
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.056
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.056
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.056
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.056
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.056
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.056
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.056
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.056
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.056
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.055
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.055
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.055
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.055
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.055
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.055
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.055
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.055
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.055
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.054
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.054
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.054
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.054
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.054
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.054
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.054
|
|
|
|
inner cell mass cellular morphogenesis
|
GO:0001828 |
1 |
0.054
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.054
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.054
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.054
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.054
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.053
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.053
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.053
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.053
|
|